The Impact of the COVID-19 Pandemic on Stress, Isolation, Smoking Behaviors, and Motivation to Quit in People with HIV Who Smoke

Patricia A. Cioe*, Robert Schnoll, Bettina B. Hoeppner, Robert Gross, Brian L. Hitsman, Frank T. Leone, Rebecca Ashare, Roger Vilardaga, Karen Tashima, Megan Pinkston, Christopher W. Kahler

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

People with HIV (PWH) smoke at higher rates compared with the general population and have lower cessation rates. The primary aim of this study was to examine the impact of the COVID-19 pandemic on smoking in PWH. A survey was administered to participants in two smoking cessation trials in the United States. Mean cigarettes per day was 13.9 (SD 8.6), and participants reported they had smoked on average for 30.93 years (SD 10.4). More than half (55.7%) of participants (N = 140) reported not changing their smoking during the pandemic, while 15% reported decreasing, and 25% reported increasing their smoking. In bivariate analyses, worrying about food due to lack of money (χ2 = 9.13, df 2, p = 0.01) and greater Covid-related worry (rs = 0.19, p = 0.02) were significantly associated with increased smoking. Qualitative research may be needed to more clearly elucidate factors related to smoking behaviors among PWH.

Original languageEnglish (US)
Pages (from-to)1862-1869
Number of pages8
JournalAIDS and behavior
Volume27
Issue number6
DOIs
StatePublished - Jun 2023

Funding

Drs. Cioe, Hoeppner, Hitsman, Pinkston, Tashima, and Kahler have no relevant financial or non-financial interests to disclose. Dr. Schnoll received medication and placebo free of charge from Pfizer for clinical trials and has provided consultation to Pfizer, GlaxoSmithKline, and Curaleaf. Dr. Ashare received an investigator-initiated grant from Novo Nordisk, Inc for a study unrelated to the current project. Dr. Vilardaga is the principal investigator in an industry trial study funded by Happify Inc. Dr. Gross serves on a DSMB for a Pfizer medication unrelated to smoking or HIV. This work is supported by the following Grants from the National Cancer Institute: R21CA243906, R21CA243911 and R01CA243914. This work was also supported by the Penn Center for AIDS Research (CFAR), (P30 AI 045008), Penn Mental Health AIDS Research Center (PMHARC) (P30 MH 097488). This work was facilitated by the Providence/Boston Center for AIDS Research (P30AI042853).

Keywords

  • COVID-19
  • People with HIV
  • Smoking
  • Stress
  • Worry

ASJC Scopus subject areas

  • Social Psychology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'The Impact of the COVID-19 Pandemic on Stress, Isolation, Smoking Behaviors, and Motivation to Quit in People with HIV Who Smoke'. Together they form a unique fingerprint.

Cite this